Non-Small Cell Lung Cancer, Version 6.2015 Featured Updates to the NCCN Guidelines

被引:322
|
作者
Ettinger, David S. [1 ]
Wood, Douglas E. [2 ]
Akerley, Wallace [3 ]
Bazhenova, Lyudmila A. [4 ]
Borghaei, Hossein [5 ]
Camidge, David Ross [6 ]
Cheney, Richard T. [7 ]
Chirieac, Lucian R. [8 ]
D'Amico, Thomas A. [9 ]
Demmy, Todd L. [7 ]
Dilling, Thomas J. [10 ]
Dobelbower, M. Chris [11 ]
Govindan, Ramaswamy [12 ,13 ]
Grannis, Frederic W., Jr. [14 ]
Horn, Leora [15 ]
Jahan, Thierry M. [16 ]
Komaki, Ritsuko [17 ]
Krug, Lee M. [18 ]
Lackner, Rudy P. [19 ]
Lanuti, Michael [20 ]
Lilenbaum, Rogerio [21 ]
Lin, Jules [22 ]
Loo, Billy W., Jr. [23 ]
Martins, Renato [24 ]
Otterson, Gregory A. [25 ,26 ]
Patel, Jyoti D. [27 ]
Pisters, Katherine M. [17 ]
Reckamp, Karen [14 ]
Riely, Gregory J. [18 ]
Rohren, Eric [17 ]
Schild, Steven E. [28 ]
Shapiro, Theresa A. [1 ]
Swanson, Scott J. [8 ]
Tauer, Kurt [29 ]
Yang, Stephen C. [1 ]
Gregory, Kristina [30 ]
Hughes, Miranda
机构
[1] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA
[2] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA
[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
[4] UC San Diego Moores Canc Ctr, San Diego, CA USA
[5] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[6] Univ Colorado, Ctr Canc, Boulder, CO 80309 USA
[7] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[8] Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02115 USA
[9] Duke Canc Inst, Durham, NC 27705 USA
[10] Moffit Canc Ctr, Tampa, FL 33612 USA
[11] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL USA
[12] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA
[13] Washington Univ, Sch Med, St Louis, MO 63130 USA
[14] City Hope Comprehens Canc Ctr, Duarte, CA USA
[15] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[16] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[17] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[18] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[19] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA
[20] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
[21] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA
[22] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA
[23] Stanford Canc Inst, Palo Alto, CA USA
[24] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA USA
[25] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA
[26] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA
[27] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA
[28] Mayo Clin, Ctr Canc, Rochester, MN USA
[29] Univ Tennessee, St Jude Childrens Hosp, Hlth Sci Ctr, Knoxville, TN 37996 USA
[30] Natl Comprehens Canc Network, Ft Washington, PA USA
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2015年 / 13卷 / 05期
关键词
GROWTH-FACTOR-RECEPTOR; TYROSINE KINASE INHIBITORS; ESMO CONSENSUS CONFERENCE; ALK GENE REARRANGEMENT; ACQUIRED-RESISTANCE; EGFR MUTATION; CLINICOPATHOLOGICAL FEATURES; TUMOR SPECIMENS; OPEN-LABEL; CRIZOTINIB;
D O I
10.6004/jnccn.2015.0071
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC). Appropriate targeted therapy is very effective in patients with advanced NSCLC who have specific genetic alterations. Therefore, it is important to test tumor tissue from patients with advanced NSCLC to determine whether they have genetic alterations that make them candidates for specific targeted therapies. These NCCN Guidelines Insights describe the different testing methods currently available for determining whether patients have genetic alterations in the 2 most commonly actionable genetic alterations, notably anaplastic lymphoma kinase (ALK) gene rearrangements and sensitizing epidermal growth factor receptor (EGFR) mutations.
引用
收藏
页码:515 / 524
页数:10
相关论文
共 50 条
  • [21] NCCN Guidelines® Insights Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017 Featured Updates to the NCCN Guidelines
    Wierda, William G.
    Zelenetz, Andrew D.
    Gordon, Leo I.
    Abramson, Jeremy S.
    Advani, Ranjana H.
    Andreadis, C. Babis
    Bartlett, Nancy
    Byrd, John C.
    Caimi, Paolo
    Fayad, Luis E.
    Fisher, Richard I.
    Glenn, Martha J.
    Habermann, Thomas M.
    Harris, Nancy Lee
    Hernandez-Ilizaliturri, Francisco
    Hoppe, Richard T.
    Horwitz, Steven M.
    Kaminski, Mark S.
    Kelsey, Christopher R.
    Kim, Youn H.
    Krivacic, Susan
    LaCasce, Ann S.
    Martin, Michael G.
    Nademanee, Auayporn
    Porcu, Pierluigi
    Press, Oliver
    Rabinovitch, Rachel
    Reddy, Nishitha
    Reid, Erin
    Roberts, Kenneth
    Saad, Ayman A.
    Snyder, Erin D.
    Sokol, Lubomir
    Swinnen, Lode J.
    Vose, Julie M.
    Yahalom, Joachim
    Dwyer, Mary A.
    Sundar, Hema
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (03): : 293 - 311
  • [22] Multiple Myeloma, Version 1.2013 Featured Updates to the NCCN Guidelines
    Anderson, Kenneth C.
    Alsina, Melissa
    Bensinger, William
    Biermann, J. Sybil
    Cohen, Adam D.
    Devine, Steven
    Djulbegovic, Benjamin
    Faber, Edward A., Jr.
    Gasparetto, Cristina
    Hernandez-Illizaliturri, Francisco
    Huff, Carol Ann
    Kassim, Adetola
    Krishnan, Amrita Y.
    Liedtke, Michael
    Meredith, Ruby
    Raje, Noopur
    Schriber, Jeffrey
    Singhal, Seema
    Somlo, George
    Stockerl-Goldstein, Keith
    Treon, Steven P.
    Weber, Donna
    Yahalom, Joachim
    Yunus, Furhan
    Shead, Dorothy A.
    Kumar, Rashmi
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (01): : 11 - 17
  • [23] Multiple Myeloma, Version 3.2022 Featured Updates to the NCCN Guidelines
    Callander, Natalie S.
    Baljevic, Muhamed
    Adekola, Kehinde
    Anderson, Larry D.
    Campagnaro, Erica
    Castillo, Jorge J.
    Costello, Caitlin
    Devarakonda, Srinivas
    Elsedawy, Noura
    Faiman, Matthew
    Garfall, Alfred
    Godby, Kelly
    Hillengass, Jens
    Holmberg, Leona
    Htut, Myo
    Huff, Carol Ann
    Hultcrantz, Malin
    Kang, Yubin
    Larson, Sarah
    Liedtke, Michaela
    Martin, Thomas
    Omel, James
    Sborov, Douglas
    Shain, Kenneth
    Stockerl-Goldstein, Keith
    Weber, Donna
    Berardi, Ryan A.
    Kumar, Rashmi
    Kumar, Shaji K.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (01): : 9 - 19
  • [24] NCCN Guidelines® Insights Chronic Myeloid Leukemia, Version 1.2017 Featured Updates to the NCCN Guidelines
    Pallera, Arnel
    Altman, Jessica K.
    Berman, Ellin
    Abboud, Camille N.
    Bhatnagar, Bhavana
    Curtin, Peter
    DeAngelo, Daniel J.
    Gotlib, Jason
    Hagelstrom, R. Tanner
    Hobbs, Gabriela
    Jagasia, Madan
    Kantarjian, Hagop M.
    Kropf, Patricia
    Metheny, Leland
    Moore, Joseph O.
    Ontiveros, Evelena
    Purev, Enkhtsetseg
    Quiery, Albert
    Reddy, Vishnu V. B.
    Rose, Michal G.
    Shah, Neil P.
    Smith, B. Douglas
    Snyder, David S.
    Sweet, Kendra L.
    Tibes, Raoul
    Yang, David T.
    Gregory, Kristina
    Sundar, Hema
    Deininger, Michael
    Radich, Jerald P.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (12): : 1505 - 1512
  • [25] Non-Small Cell Lung Cancer, Version 5.2017 Clinical Practice Guidelines in Oncology
    Ettinger, David S.
    Wood, Douglas E.
    Aisner, Dara L.
    Akerley, Wallace
    Bauman, Jessica
    Chirieac, Lucian R.
    D'Amico, Thomas A.
    DeCamp, Malcolm M.
    Dilling, Thomas J.
    Dobelbower, Michael
    Doebele, Robert C.
    Govindan, Ramaswamy
    Gubens, Matthew A.
    Hennon, Mark
    Horn, Leora
    Komaki, Ritsuko
    Lackner, Rudy P.
    Lanuti, Michael
    Leal, Ticiana A.
    Leisch, Leah J.
    Lilenbaum, Rogerio
    Lin, Jules
    Loo, Billy W., Jr.
    Martins, Renato
    Otterson, Gregory A.
    Reckamp, Karen
    Riely, Gregory J.
    Schild, Steven E.
    Shapiro, Theresa A.
    Stevenson, James
    Swanson, Scott J.
    Tauer, Kurt
    Yang, Stephen C.
    Gregory, Kristina
    Hughes, Miranda
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (04): : 504 - 535
  • [26] Non-Hodgkin's Lymphomas, Version 3.2016 Featured Updates to the NCCN Guidelines
    Horwitz, Steven M.
    Zelenetz, Andrew D.
    Gordon, Leo I.
    Wierda, William G.
    Abramson, Jeremy S.
    Advani, Ranjana H.
    Andreadis, C. Babis
    Bartlett, Nancy
    Byrd, John C.
    Fayad, Luis E.
    Fisher, Richard I.
    Glenn, Martha J.
    Habermann, Thomas M.
    Harris, Nancy Lee
    Hernandez-Ilizaliturri, Francisco
    Hoppe, Richard T.
    Kaminski, Mark S.
    Kelsey, Christopher R.
    Kim, Youn H.
    Krivacic, Susan
    LaCasce, Ann S.
    Lunning, Matthew
    Nademanee, Auayporn
    Press, Oliver
    Rabinovitch, Rachel
    Reddy, Nishitha
    Reid, Erin
    Roberts, Kenneth
    Saad, Ayman A.
    Sokol, Lubomir
    Swinnen, Lode J.
    Vose, Julie M.
    Yahalom, Joachim
    Zafar, Nadeem
    Dwyer, Mary
    Sundar, Hema
    Porcu, Pierluigi
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (09): : 1067 - 1079
  • [27] Non-Small Cell Lung Cancer, Version 3.2022
    Ettinger, David S.
    Wood, Douglas E.
    Aisner, Dara L.
    Akerley, Wallace
    Bauman, Jessica R.
    Bharat, Ankit
    Bruno, Debora S.
    Chang, Joe Y.
    Chirieac, Lucian R.
    D'Amico, Thomas A.
    DeCamp, Malcolm
    Dilling, Thomas J.
    Dowell, Jonathan
    Gettinger, Scott
    Grotz, Travis E.
    Gubens, Matthew A.
    Hegde, Aparna
    Lackner, Rudy P.
    Lanuti, Michael
    Lin, Jules
    Loo, Billy W.
    Lovly, Christine M.
    Maldonado, Fabien
    Massarelli, Erminia
    Morgensztern, Daniel
    Ng, Thomas
    Otterson, Gregory A.
    Pacheco, Jose M.
    Patel, Sandip P.
    Riely, Gregory J.
    Riess, Jonathan
    Schild, Steven E.
    Shapiro, Theresa A.
    Singh, Aditi P.
    Stevenson, James
    Tam, Alda
    Tanvetyanon, Tawee
    Yanagawa, Jane
    Yang, Stephen C.
    Yau, Edwin
    Gregory, Kristina
    Hughes, Miranda
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (05): : 497 - 530
  • [28] Non-Small Cell Lung Cancer, Version 4.2024
    Riely, Gregory J.
    Wood, Douglas E.
    Ettinger, David S.
    Aisner, Dara L.
    Akerley, Wallace
    Bauman, Jessica R.
    Bharat, Ankit
    Bruno, Debora S.
    Chang, Joe Y.
    Chirieac, Lucian R.
    Decamp, Malcolm
    Desai, Aakash P.
    Dilling, Thomas J.
    Dowell, Jonathan
    Durm, Gregory A.
    Gettinger, Scott
    Grotz, Travis E.
    Gubens, Matthew A.
    Juloori, Aditya
    Lackner, Rudy P.
    Lanuti, Michael
    Lin, Jules
    Loo, Billy W., Jr.
    Lovly, Christine M.
    Maldonado, Fabien
    Massarelli, Erminia
    Morgensztern, Daniel
    Mullikin, Trey C.
    Ng, Thomas
    Owen, Dawn
    Owen, Dwight H.
    Patel, Sandip P.
    Patil, Tejas
    Polanco, Patricio M.
    Riess, Jonathan
    Shapiro, Theresa A.
    Singh, Aditi P.
    Stevenson, James
    Tam, Alda
    Tanvetyanon, Tawee
    Yanagawa, Jane
    Yang, Stephen C.
    Yau, Edwin
    Gregory, Kristina M.
    Hang, Lisa
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (04): : 249 - 274
  • [29] Updates in the molecular pathology of non-small cell lung cancer
    Paver, Elizabeth
    O'Toole, Sandra
    Cheng, Xin Min
    Mahar, Annabelle
    Cooper, Wendy A.
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2021, 38 (05) : 54 - 61
  • [30] Gastrointestinal Stromal Tumors Version 2.2022 Featured Updates to the NCCN Guidelines
    von Mehren, Margaret
    Kane, John M.
    Riedel, Richard F.
    Sicklick, Jason K.
    Pollack, Seth M.
    Agulnik, Mark
    Bui, Marilyn M.
    Carr-Ascher, Janai
    Choy, Edwin
    Connelly, Mary
    Dry, Sarah
    Ganjoo, Kristen N.
    Gonzalez, Ricardo J.
    Holder, Ashley
    Homsi, Jade
    Keedy, Vicki
    Kelly, Ciara M.
    Kim, Edward
    Liebner, David
    McCarter, Martin
    McGarry, Sean, V
    Mesko, Nathan W.
    Meyer, Christian
    Pappo, Alberto S.
    Parkes, Amanda M.
    Petersen, Ivy A.
    Poppe, Matthew
    Schuetze, Scott
    Shabason, Jacob
    Spraker, Matthew B.
    Zimel, Melissa
    Bergman, Mary Anne
    Sundar, Hema
    Hang, Lisa E.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (11): : 1204 - 1214